Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H8O2 |
Molecular Weight | 88.1051 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C1COCOC1
InChI
InChIKey=VDFVNEFVBPFDSB-UHFFFAOYSA-N
InChI=1S/C4H8O2/c1-2-5-4-6-3-1/h1-4H2
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Split--pool synthesis of 1,3-dioxanes leading to arrayed stock solutions of single compounds sufficient for multiple phenotypic and protein-binding assays. | 2001 Feb 28 |
|
Simultaneous discrimination of diastereotopic groups and faces: the first example in intramolecular [3+2] and [2+2+1] cycloaddition reactions. | 2001 Jun 1 |
|
Electronic delocalization contribution to the anomeric effect evaluated by computational methods. | 2001 May 4 |
|
Effect of geminal substitution on the strain energy of dioxiranes. Origin of the low ring strain of dimethyldioxirane. | 2002 May 31 |
|
Structural biasing elements for in-cell histone deacetylase paralog selectivity. | 2003 May 14 |
|
Modular synthesis and preliminary biological evaluation of stereochemically diverse 1,3-dioxanes. | 2004 Sep |
|
Relationships between the structure of dexoxadrol and etoxadrol analogues and their NMDA receptor affinity. | 2006 |
|
5,5-Bis(hydroxy-meth-yl)-2-phenyl-1,3-dioxane. | 2008 Jul 19 |
|
2,3:4,6-Di-O-isopropylidene-alpha-L-sorbofuranose and 2,3-O-isopropylidene-alpha-L-sorbofuranose. | 2009 Apr |
|
7,14-Bis(4-methoxy-phen-yl)-11,11-dimethyl-1,4,10,12-tetra-oxa-dispiro-[4.2.5.2]penta-decane-9,13-dione. | 2009 Apr 18 |
|
7,14-Bis(4-bromo-phen-yl)-2,11,11-trimethyl-1,4,10,12-tetra-oxa-dispiro-[4.2.5.2]penta-decane-9,13-dione. | 2009 Apr 30 |
|
2,2-Dimethyl-5-triphenyl-methyl-1,3-dioxane. | 2009 Jan 14 |
|
Biodegradation of 1,4-dioxane and transformation of related cyclic compounds by a newly isolated Mycobacterium sp. PH-06. | 2009 Jul |
|
3-(2-Furylmethyl-ene)-1,5-dioxaspiro-[5.5]undecane-2,4-dione. | 2009 Jul 15 |
|
Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists. | 2009 Jul 15 |
|
3-[(5-Methyl-furan-2-yl)methyl-ene]-1,5-dioxaspiro-[5.5]undecane-2,4-dione. | 2009 Jul 29 |
|
Synthetic mRNA splicing modulator compounds with in vivo antitumor activity. | 2009 Nov 26 |
|
2-(2-Nitro-phen-yl)-1,3-dioxan-5-ol. | 2009 Oct 28 |
|
5-(2-Fluoro-benzyl-idene)-2,2-dimethyl-1,3-dioxane-4,6-dione. | 2009 Sep 30 |
|
(Z)-3-(3-Phenyl-allyl-idene)-1,5-dioxa-spiro-[5.5]undecane-2,4-dione. | 2009 Sep 30 |
|
3,9-Di-1-naphthyl-2,4,8,10-tetra-oxa-spiro-[5.5]undeca-ne. | 2010 Apr 28 |
|
5-(4-Hy-droxy-benzyl-idene)-2,2-dimethyl-1,3-dioxane-4,6-dione. | 2010 Aug 18 |
|
5-(4-Fluoro-benzyl-idene)-2,2-dimethyl-1,3-dioxane-4,6-dione. | 2010 Aug 21 |
|
(E)-1-[(1,3-Dioxan-4-yl)meth-yl]-2-(nitro-methyl-idene)imidazolidine. | 2010 Aug 21 |
|
Product study of the OH radical and Cl atom initiated oxidation of 1,3-dioxane. | 2010 Dec 17 |
|
3,9-Bis(2-chloro-phen-yl)-2,4,8,10-tetra-oxaspiro-[5.5]undeca-ne. | 2010 Jan 23 |
|
2-(2-Naphth-yl)-1,3-dioxane. | 2010 Jan 30 |
|
3,9-Bis(2,4-dichloro-phen-yl)-2,4,8,10-tetra-oxaspiro-[5.5]undeca-ne. | 2010 Jun 30 |
|
Bifunctional hydrogen bonds in monohydrated cycloether complexes. | 2010 Mar 4 |
|
Xyloccensin e. | 2010 May 15 |
|
3,9-Di-tert-butyl-2,4,8,10-tetra-oxaspiro-[5.5]undeca-ne. | 2010 Nov 30 |
|
Stereoselective α,α'-annelation reactions of 1,3-dioxan-5-ones. | 2010 Nov 5 |
|
3-(4-Meth-oxy-benzyl-idene)-1,5-dioxa-spiro-[5.5]undecane-2,4-dione. | 2010 Oct 20 |
|
3,3,9,9-Tetra-phenyl-2,4,8,10-tetra-oxa-spiro-[5.5]undeca-ne. | 2010 Oct 31 |
|
Synthesis and characterization of novel indole derivatives reveal improved therapeutic agents for treatment of ischemia/reperfusion (I/R) injury. | 2010 Sep 23 |
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
B2C8M17I09
Created by
admin on Fri Dec 15 17:12:47 GMT 2023 , Edited by admin on Fri Dec 15 17:12:47 GMT 2023
|
PRIMARY | |||
|
46924
Created by
admin on Fri Dec 15 17:12:47 GMT 2023 , Edited by admin on Fri Dec 15 17:12:47 GMT 2023
|
PRIMARY | |||
|
139436
Created by
admin on Fri Dec 15 17:12:47 GMT 2023 , Edited by admin on Fri Dec 15 17:12:47 GMT 2023
|
PRIMARY | |||
|
DTXSID3025174
Created by
admin on Fri Dec 15 17:12:47 GMT 2023 , Edited by admin on Fri Dec 15 17:12:47 GMT 2023
|
PRIMARY | |||
|
208-005-1
Created by
admin on Fri Dec 15 17:12:47 GMT 2023 , Edited by admin on Fri Dec 15 17:12:47 GMT 2023
|
PRIMARY | |||
|
10450
Created by
admin on Fri Dec 15 17:12:47 GMT 2023 , Edited by admin on Fri Dec 15 17:12:47 GMT 2023
|
PRIMARY | |||
|
505-22-6
Created by
admin on Fri Dec 15 17:12:47 GMT 2023 , Edited by admin on Fri Dec 15 17:12:47 GMT 2023
|
PRIMARY | |||
|
4263
Created by
admin on Fri Dec 15 17:12:47 GMT 2023 , Edited by admin on Fri Dec 15 17:12:47 GMT 2023
|
PRIMARY | |||
|
1,3-Dioxane
Created by
admin on Fri Dec 15 17:12:47 GMT 2023 , Edited by admin on Fri Dec 15 17:12:47 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD